openPR Logo
Press release

Analgesics Market: Projected Compound Growth Rate 6.6% and Future Outlook 2030

08-24-2023 01:39 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Analgesics Market: Projected Compound Growth Rate 6.6%

The global analgesics industry was estimated at $26.7 billion in 2020, and is anticipated to hit $50.7 billion by 2030, registering a CAGR of 6.6% from 2021 to 2030.

Request Sample Copy of Report:

https://www.alliedmarketresearch.com/request-sample/1254

Technological Advancements: The market has witnessed technological advancements in pain management, including the development of new drug formulations and delivery systems. These innovations aim to improve efficacy, minimize side effects, and enhance patient compliance.

Regional Variations: The analgesics market shows regional variations in terms of product availability, regulatory frameworks, and consumer preferences. Different countries may have varying levels of access to certain analgesics or different guidelines for their use.

Market Segmentation:

Product Type:
a. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): This segment includes medications like ibuprofen, aspirin, and naproxen, which reduce pain and inflammation.
b. Acetaminophen (Paracetamol): Acetaminophen is a commonly used analgesic for relieving pain and reducing fever.
c. Opioids: This segment comprises potent pain relievers, including drugs like oxycodone, morphine, and codeine, typically used for moderate to severe pain.
d. Others: This category encompasses various analgesics that may have different mechanisms of action, such as muscle relaxants and topical analgesics.

Prescription-based vs. Over-the-Counter (OTC):
a. Prescription Analgesics: These are medications that require a prescription from a healthcare professional, typically used for more severe or chronic pain conditions.
b. Over-the-Counter (OTC) Analgesics: These are medications available without a prescription, commonly used for mild to moderate pain relief.

Route of Administration:
a. Oral Analgesics: Medications that are taken orally, such as tablets, capsules, or liquid formulations.
b. Topical Analgesics: Analgesics in the form of creams, gels, patches, or sprays that are applied directly to the skin for localized pain relief.
c. Parenteral Analgesics: Medications administered through injections or intravenous infusion, often used in hospital settings for acute or severe pain management.

Distribution Channel:
a. Retail Pharmacies: Analgesics available for purchase through traditional retail pharmacy outlets.
b. Online Pharmacies: Increasingly popular channels for purchasing analgesics, providing convenience and accessibility for consumers.
c. Hospital Pharmacies: Analgesics supplied and administered within hospital settings.

End User:
a. Hospitals and Clinics: Analgesics used in inpatient and outpatient settings for pain management.
b. Homecare: Analgesics used by individuals in home settings for self-care or under the guidance of healthcare professionals.
c. Others: This category includes various end users, such as long-term care facilities, rehabilitation centers, and ambulatory surgical centers.

Geography:
The analgesics market can also be segmented based on regional or country-specific factors, such as regulatory frameworks, healthcare systems, and consumer preferences.

Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/1254

Regional Growth Dynamics:

By region, the market across North America had the lion's share in 2020, generating nearly one-third of the global analgesics market, owing to increase in demand for non-opioids drugs, presence of key players, and development in R&D activities in the healthcare sector in the province. The Asia-Pacific region, on the other hand, is projected to portray the fastest CAGR of 7.3% by 2030. This is due to rise in awareness about the use of analgesic drugs, growth in healthcare expenditures, and surge in adoption of analgesic products.

Competitive Landscape:

Johnson & Johnson
Pfizer Inc.
GlaxoSmithKline plc
Novartis International AG
Bayer AG
Sanofi S.A.
Reckitt Benckiser Group plc
Teva Pharmaceutical Industries Ltd.
Endo International plc
Eli Lilly and Company

Procure Complete Report at 20% Discount (258 Pages): https://www.alliedmarketresearch.com/purchase-enquiry/1254

Related Reports :

Consumer Healthcare Market https://www.alliedmarketresearch.com/consumer-healthcare-market

Penicillin Drug Market https://www.alliedmarketresearch.com/penicillin-drug-market-A110795

Metastatic Cancer Drugs Market https://www.alliedmarketresearch.com/metastatic-cancer-drugs-market-A109351

Diabetic Foot Ulcer Treatment Market https://www.alliedmarketresearch.com/diabetic-foot-ulcer-treatment-market-A110954

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Analgesics Market: Projected Compound Growth Rate 6.6% and Future Outlook 2030 here

News-ID: 3180040 • Views: …

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…

All 5 Releases


More Releases for Analgesics

Key Influencer in the Analgesics Market 2025: Elevated Prevalence Of Chronic Dis …
"How Are the key drivers contributing to the expansion of the analgesics market? The growing frequency of chronic health conditions fuels the expansion of the analgesics market. Analgesics, colloquially known as painkillers, are employed in combating extreme or long-lasting pain resulting from a variety of health disorders. For instance, a report from the World Health Organization (WHO) in September 2022 pointed out that chronic diseases, also dubbed noncommunicable diseases (NCDs), materialize…
Market Growth Opportunity in Analgesics
Global Analgesics Market: Overview Analgesics, or painkillers, are used to reduce and treat aches and pains. Internal and external analgesics are used to combat pain resulting from inflammation, cancer treatments, physiological injury, neuropathic conditions, surgeries, wounds, and phantom aches. The most prominent therapeutic classes of analgesics are local anesthesia, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids. The growing incidence of cancer worldwide and the rise in chronic diseases are mainly responsible for…
Global Antipyretic Analgesics Market Demand 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Antipyretic Analgesics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Antipyretic Analgesics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). GLOBAL INFO RESEARCH has recently published a research report titled, [Global Antipyretic Analgesics Market 2020 by Company, Regions, Type and Application, Forecast to…
Narcotic Analgesics: Future of Chronic Pain Management
The development of tolerance for non-narcotic analgesics is the primarily reason behind the constantly increasing sales for narcotic analgesics. Attributing to the higher efficacy in pain management and quick onset of action, narcotic analgesics are largely used in palliative care services for treating patients suffering from neuropathic pain. Increasing focus on palliative care services in third world countries and readily available reimbursements are the key factors expected to boost the…
Analgesics Market - Global Industry Analysis 2024
Analgesics, or painkillers, are used to reduce and treat aches and pains. Internal and external analgesics are used to combat pain resulting from inflammation, cancer treatments, physiological injury, neuropathic conditions, surgeries, wounds, and phantom aches. The most prominent therapeutic classes of analgesics are local anesthesia, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids. The growing incidence of cancer worldwide and the rise in chronic diseases are mainly responsible for the consistent growth…
Global Antipyretic Analgesics Sales Market Report 2017
This report studies sales (consumption) of Antipyretic Analgesics in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Crown Pharmaceuticals Medipaams India SRS Pharmaceuticals Umang Pharma YaoPharma ... Market Segment by…